Former FDA chief Gottlieb on difficulties distributing Covid antibody drugs

Eli Lilly said Wednesday its Covid antibody therapy reduced the risk of hospitalization and death by 87% in a study of more than 750 high-risk coronavirus patients. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joined "Squawk Box" on Wednesday to discuss.